Find a Tender Service

S&P25020 - Second Tier Testing SYBP & LTHT

Sheffield Teaching Hospitals NHS Foundation Trust

Awarded
services

This tender has closed

The submission deadline for this contract has passed. There may be more active services tenders from Sheffield Teaching Hospitals NHS Foundation Trust, and hundreds more across the UK public sector.

Key details

Region
Sheffield
Delivery: UKE32
Contract value
£15,000ex VAT
Submissions closed
Not stated by buyer
Published
27 January 2026

Procurement

Procedure type
Award procedure without prior publication of a call for competition
CPV classifications
  • 85111810 Blood analysis services
  • 71900000 Laboratory services

What happened

Sheffield Teaching Hospitals NHS Foundation Trust awarded this contract to LEEDS TEACHING HOSPITALS NHS TRUST worth £15,000 on 1 Apr 2025.

Description

PROVISION OF CLINICAL LABORATORY SERVICES :

SECOND TIER TESTING (by HPLC) OF BLOODSPOT SAMPLES AS PART OF NEWBORN SCREENING PROGRAMME FOR SICKLE CELL AND THALASSAEMIA

Full description

Provider will deliver confirmatory testing for newborn screening results for sickle cell disease obtained from LS-MS/MS analysis in the Newborn Screening Laboratory at Sheffield Children’s Hospital using High Performance Liquid Chromatography (HPLC). This analysis constitutes the second tier testing required as part of the Newborn Screening Programme for Sickle Cell and Thalassaemia

This contract has been awarded under NHS Provider Selection Regime Direct Award A. The Provider is currently meeting all contractual and legislative requirements as detailed in the NHS Standard Subcontract.

The services will be provided under this contract for 12 months from 1 April 2025 to 31 March 2026

Awarded supplier

Supplier
LEEDS TEACHING HOSPITALS NHS TRUST
Award value
£15,000
Award date
1 April 2025

Contact

Address
Herries Road, Sheffield, S5 7AU
Contact name
Nabs Ilyas

Identifiers

Notice ID
007039-2026
OCID
ocds-h6vhtk-060f87

Explore related tenders

External ID: fts-ocds-h6vhtk-060f87 • Added 6 August 2026